Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions
Clinical trial NCT05417893 · WITHDRAWN
Trial details
- NCT number
- NCT05417893
- Sponsor
- Meril Life Sciences Pvt. Ltd.
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-15
- Primary completion
- 2023-09-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.